CRL vs ICUI · rev $2.00B vs P/E 74, rev $1.08B
Charles River Laboratories (CRL) versus ICU Medical Inc (ICUI) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
ICU Medical Inc (ICUI) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported ICUI revenue for 2026-06-30 was $1.08B. Net income was $49.2M. ICUI currently screens at market cap $3.45B and trailing P/E 73.8.
CRL currently screens at market cap $7.78B. ICUI currently screens at market cap $3.45B and trailing P/E 73.8.
Not investment advice. Open the CRL and ICUI stock pages for the full models.
Not investment advice.